Cargando…
Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma
MicroRNA (miRNA)-based therapies are an emerging class of targeted therapeutics with many potential applications. Ewing Sarcoma patients could benefit dramatically from personalized miRNA therapy due to inter-patient heterogeneity and a lack of druggable (to this point) targets. However, because of...
Autores principales: | Weaver, Davis T., Pishas, Kathleen I., Williamson, Drew, Scarborough, Jessica, Lessnick, Stephen L., Dhawan, Andrew, Scott, Jacob G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601628/ https://www.ncbi.nlm.nih.gov/pubmed/34662337 http://dx.doi.org/10.1371/journal.pcbi.1008755 |
Ejemplares similares
-
Recent advances in targeted therapy for Ewing sarcoma
por: Pishas, Kathleen I., et al.
Publicado: (2016) -
Identifying States of Collateral Sensitivity during the Evolution of Therapeutic Resistance in Ewing's Sarcoma
por: Scarborough, Jessica A., et al.
Publicado: (2020) -
Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
por: Theisen, Emily R., et al.
Publicado: (2016) -
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation
por: Pishas, Kathleen I., et al.
Publicado: (2018) -
Investigating the role of LSD2 as an epigenetic regulator in Ewing sarcoma
por: Patel, Priyal O., et al.
Publicado: (2019)